Synthèse et études d'hétérodimères spécifiques des sites abasiques de l'ADN - Potentialisation d'agents alkylants anticancéreux = Synthesis and studies of heterodimers that specifically recognize abasic sites in DNA-Potentiation of antitumour DNA alkylating drugsAlarcon, Karine; Demeunynck, Martine.2000, 231 p.Thesis

Phase III Randomized Study of Rituximab/Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) Compared With Iodine-131 Tositumomab/BEAM With Autologous Hematopoietic Cell Transplantation for Relapsed Diffuse Large B-Cell Lymphoma: Results From the BMT CTN 0401 TrialVOSE, Julie M; CARTER, Shelly; HOROWITZ, Mary et al.Journal of clinical oncology. 2013, Vol 31, Num 13, pp 1662-1668, issn 0732-183X, 7 p.Article

Preservation of Neurocognitive Function and Local Control of 1 to 3 Brain Metastases Treated With Surgery and Carmustine WafersBREM, Steven; MEYERS, Christina A; PALMER, Gary et al.Cancer. 2013, Vol 119, Num 21, pp 3830-3838, issn 0008-543X, 9 p.Article

O⁶-Methylguanine-DNA Methyltransferase (MGMT) Promoter Methylation and Low MGMT-Encoded Protein Expression as Prognostic Markers in Glioblastoma Patients Treated With Biodegradable Carmustine Wafer Implants After Initial Surgery Followed by Radiotherapy With Concomitant and Adjuvant TemozolomideLECHAPT-ZALCMAN, Emmanuèle; LEVALLET, Guénaëlle; CHAPON, Françoise et al.Cancer. 2012, Vol 118, Num 18, pp 4545-4554, issn 0008-543X, 10 p.Article

Prognosis after high-dose chemotherapy followed by autologous stem-cell transplantation as first-line treatment in primary CNS Iymphoma―a long-term follow-up studyKASENDA, B; SCHORB, E; FRITSCH, K et al.Annals of oncology. 2012, Vol 23, Num 10, pp 2670-2675, issn 0923-7534, 6 p.Article

RETROSPECTIVE COMPARISON OF CHEMORADIOTHERAPY FOLLOWED BY ADJUVANT CHEMOTHERAPY, WITH OR WITHOUT PRIOR GLIADEL IMPLANTATION (CARMUSTINE) AFTER INITIAL SURGERY IN PATIENTS WITH NEWLY DIAGNOSED HIGH-GRADE GLIOMASNOËL, Georges; SCHOTT, Roland; FROELICH, Sébastien et al.International journal of radiation oncology, biology, physics. 2012, Vol 82, Num 2, pp 749-755, issn 0360-3016, 7 p.Article

Carmustine Wafer Implantation When Surgical Cavity Is Communicating with Cerebral Ventricles: Technical Considerations on a Clinical SeriesDELLA PUPPA, Alessandro; ROSSETTO, Marta; CICCARINO, Pietro et al.World neurosurgery (Print). 2011, Vol 76, Num 1-2, pp 156-159, issn 1878-8750, 4 p.Article

Candida Meningitis Post Gliadel Wafer Placement Successfully Treated with Intrathecal and Intravenous Amphotericin BGLICK, Jorie A; GRAHAM, Robert S; VOILS, Stacy A et al.The Annals of pharmacotherapy. 2010, Vol 44, Num 1, pp 215-218, issn 1060-0280, 4 p.Article

Extended O⁶-Methylguanine Methyltransferase Promoter Hypermethylation Following n-Butylidenephthalide Combined with 1,3-Bis(2-chloroethyl)-1-nitrosourea (BCNU) on Inhibition of Human Hepatocellular Carcinoma Cell GrowthYU, Yung-Luen; YU, Sung-Liang; LIN, Shinn-Zong et al.Journal of agricultural and food chemistry (Print). 2010, Vol 58, Num 3, pp 1630-1638, issn 0021-8561, 9 p.Article

Quantitative relationship between guanine O⁶-alkyl lesions produced by Onrigin™ and tumor resistance by O⁶-alkylguanine-DNA alkyltransferaseISHIGURO, Kimiko; ZHU, Yong-Lian; SHYAM, Krishnamurthy et al.Biochemical pharmacology. 2010, Vol 80, Num 9, pp 1317-1325, issn 0006-2952, 9 p.Article

The Treatment of Multiple Myeloma Using Vincristine, Carmustine, Melphalan, Cyclophosphamide, and Prednisone (VBMCP) Alternating With High-dose Cyclophosphamide and α₂β Interferon Versus VBMCP Results of a Phase III Eastern Cooperative Oncology Group Study E5A93KYLE, Robert A; JACOBUS, Susanna; FRIEDENBERG, William R et al.Cancer. 2009, Vol 115, Num 10, pp 2155-2164, issn 0008-543X, 10 p.Article

Intracavitary chemotherapy (Gliade®) and oral low-dose etoposide for recurrent anaplastic ependymomaSARDI, Iacopo; SANZO, Massimiliano; GIORDANO, Flavio et al.Oncology reports. 2008, Vol 19, Num 5, pp 1219-1223, issn 1021-335X, 5 p.Article

Treatment of single brain metastasis with resection, intracavity carmustine polymer wafers, and radiation therapy is safe and provides excellent local controlEWEND, Matthew G; BREM, Steven; GILBERT, Mark et al.Clinical cancer research. 2007, Vol 13, Num 12, pp 3637-3641, issn 1078-0432, 5 p.Article

Chlorméthine (Caryolysine®), carmustine (Bicnu®) = Chlormethine (Caryolysine®), carmustin (Bicnu®)ESTEVE, E; GRANGE, F.Annales de dermatologie et de vénéréologie. 2007, Vol 134, Num 12, pp 992-996, issn 0151-9638, 5 p.Article

Intracavitary chemotherapy (Gliadel®) for recurrent esthesioneuroblastoma : Case report and review of the literaturePARK, Michael C; WEAVER, Charles E; DONAHUE, John E et al.Journal of neuro-oncology. 2006, Vol 77, Num 1, pp 47-51, issn 0167-594X, 5 p.Article

Autologous stem cell transplantation for progressive multiple sclerosis : Update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party databaseSACCARDI, R; KOZAK, T; GUALANDI, F et al.Multiple sclerosis. 2006, Vol 12, Num 6, pp 814-823, issn 1352-4585, 10 p.Article

In vivo delivery of BCNU from a MEMS device to a tumor modelYAWEN LI; HONG LINH HO DUC; TYLER, Betty et al.Journal of controlled release. 2005, Vol 106, Num 1-2, pp 138-145, issn 0168-3659, 8 p.Article

Inactivation of p53 sensitizes astrocytic glioma cells to BCNU and temozolomide, but not cisplatinWEI XU, G; MYMRYK, Joe S; CAIRNCROSS, J. Gregory et al.Journal of neuro-oncology. 2005, Vol 74, Num 2, pp 141-149, issn 0167-594X, 9 p.Article

A single prior course of BCNU-cisplatin chemotherapy has a significant deleterious effect on mobilization kinetics of otherwise untreated patientsPEREZ-CALVO, J; FERNANDEZ, O; ARISTU, J. J et al.Bone marrow transplantation (Basingstoke). 2004, Vol 33, Num 5, pp 499-502, issn 0268-3369, 4 p.Article

Interstitial infusion of carmustine in the rat brain stem with systemic administration of O⁶-benzylguanineSOUWEIDANE, Mark M; OCCHIOGROSSO, Giuseppe; MARK, Erika B et al.Journal of neuro-oncology. 2004, Vol 67, Num 3, pp 319-326, issn 0167-594X, 8 p.Article

Synergistic cytotoxicity of the ribonucleotide reductase inhibitor didox (3,4-dihydroxy-benzohydroxamic acid) and the alkylating agent carmustine (BCNU) in 9L rat gliosarcoma cells and DAOY human medulloblastoma cellsHORVATH, Zsuzsanna; HÖCHTL, Thomas; BAUER, Wolfgang et al.Cancer chemotherapy and pharmacology. 2004, Vol 54, Num 2, pp 139-145, issn 0344-5704, 7 p.Article

Formation of DNA adducts and tumor growth delay following intratumoral administration of DTI-015BODELL, William J; GIANNINI, Donald D; SINGH, Saira et al.Journal of neuro-oncology. 2003, Vol 62, Num 3, pp 251-258, issn 0167-594X, 8 p.Article

Myeloid clonogenic assays for comparison of the in vitro toxicity of alkylating agentsVOLPE, D. A; WARREN, M. K.Toxicology in vitro. 2003, Vol 17, Num 3, pp 271-277, issn 0887-2333, 7 p.Article

Phase II trial of thalidomide and carmustine for patients with recurrent high-grade gliomasFINE, Howard A; WEN, Patrick Y; MAHER, Elizabeth A et al.Journal of clinical oncology. 2003, Vol 21, Num 12, pp 2299-2304, issn 0732-183X, 6 p.Article

Gliadel therapy given for first resection of malignant glioma: a single centre study of the potential use of GliadelWHITTLE, I. R; LYLES, S; WALKER, M et al.British journal of neurosurgery (Print). 2003, Vol 17, Num 4, pp 352-354, issn 0268-8697, 3 p.Article